DelveInsight has launched a new report on “Vitiligo-Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Vitiligo–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Vitiligo, historical and forecasted epidemiology as well as the Vitiligo market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
-
DelveInsight’s epidemiology model suggests that overall, female population was found to be more prevalent than male population.
-
The total prevalent population of Vitiligo in the seven major markets was approximately 6,234,655 in 2017.
-
The United States accounted for the highest prevalent cases with around 2,663,753 prevalent cases in 2017, followed by Japan (approximately 2,141,164 cases) and EU5.
-
Among the European countries, Germany has the highest prevalent population with approximately 472,057 cases followed by the UK which has prevalent population of approximately 290,965 in 2017.
-
France has the lowest number of prevalent cases, among EU-5 countries, with around 188,196 cases in 2017.
Key benefits of the report:
1.The Vitiligo market report covers a descriptive overview and comprehensive insight of the Vitiligo epidemiology and Vitiligo market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2.The Vitiligo market report provides insights into the current and emerging therapies.
3.Vitiligo market report provides a global historical and forecasted market covering drug outreach in 7MM.
4.The Vitiligo market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Vitiligo market.
Request for sample pages: https://www.delveinsight.com/sample-request/vitiligo-market
Vitiligo: Overview
Vitiligo is a disease that causes the loss of skin color in patches. Colored areas usually grow over time. The condition can affect the skin on any part of the body. It can also affect the hair and the inside of the mouth.
Usually, hair and skin color are determined by melanin. Vitiligo occurs when cells that produce melanin die or stop functioning. Vitiligo affects people of all skin types, but can be most noticeable in people with darker skin. The condition is not life threatening or contagious. It can be stressful or can make you feel bad about yourself.
Treatment for vitiligo can restore color to the affected skin. But it does not prevent further loss of skin color or recurrence.
The key players involved in the Vitiligo market:
1. Incyte Corporation
2. Clinuvel Pharmaceutical
The launch of the emerging therapies is expected to significantly impact the Vitiligo treatment scenario in the upcoming years:-
Drug covered
-
INCB018424
-
SCENESSE (afamelanotide)
Request a free sample report @https://www.delveinsight.com/sample-request/vitiligo-market
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Vitiligo Patient Share (%) Overview at a Glance
5. Vitiligo Market Overview at a Glance
6. Vitiligo Disease Background and Overview
7. Vitiligo Epidemiology and Patient Population
8. Country-Specific Patient Population of Vitiligo
9. Vitiligo Current Treatment and Medical Practices
10. Unmet Needs
11. Vitiligo Emerging Therapies
12. Vitiligo Market Outlook
13. Country-Wise Vitiligo Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Vitiligo Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Vitiligo-Pipeline Insights, 2021
“Vitiligo-Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Vitiligo market. A detailed picture of the Vitiligo pipeline landscape is provided, which includes the disease overview and Vitiligo treatment guidelines.
Vitiligo-Epidemiology Forecast to 2030
DelveInsight’s ‘Vitiligo-Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Vitiligo{;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.www.delveinsight.com/report-store/vitiligo-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=kpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/